Abstract: A mobile station (4) in a satellite mobile telephone system predicts when it will move into another cell on the basis of one set of broadcast information thereby reducing the overall processing burden. The mobile station (4) can predict with a useful degree of certainty which broadcast control channel (BOCH) frequencies it should listen on when it wakes up on the basis of a stored map of the relative positions of cells. The broadcast information is valid for a predetermined time interval. Upon waking up, the mobile station (4) determines present time within the predetermined time interval and uses the broadcast information as well as the present time within the predetermined time interval to predict the time at which the mobile telephone will leave the cell.
Abstract: Aryl- and heteroaryl-substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.
Type:
Application
Filed:
August 18, 2005
Publication date:
December 25, 2008
Applicant:
Icos Corporation
Inventors:
John Joseph Gaudino, Francine S. Farouz, Ryan Coatsworth Holcomb, Eugene D. Thorsett
Abstract: The present invention relates to methods for making multimeric proteins comprising fusion of two or more cells expressing a single subunit of the multimeric protein to generate a single hybrid cell expressing the fully assembled multimeric protein.
Abstract: In a cellular mobile telephone system, a mobile station (4d, 4e) requests allocation of a traffic channel by sending a request in a random access channel. Where there is a significant path length difference between locations in a cell and a network antenna, for instance on a satellite (3), not all of the available TDMA slots are used for random access signals. Instead, gaps of one to three time slots are left between valid random access time slots (103, 104) to avoid collision between random access bursts arriving at the network antenna along paths of different lengths.
Abstract: Compounds that inhibit PI3K? activity, including compounds that selectively inhibit PI3K? activity, are disclosed. Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3K?) activity, and methods of treating diseases, such as disorders of immunity and inflammation in which PI3K? plays a role in leukocyte function, using the compounds also are disclosed.
Type:
Application
Filed:
May 12, 2005
Publication date:
November 6, 2008
Applicant:
ICOS CORPORATION
Inventors:
Kerry W. Fowler, Danwen Huang, Edward A. Kesicki, Hua Chee Ooi, Amy R. Oliver, Ruan Fuqiang, Jennifer Treiberg
Abstract: A device for measuring in three dimensions a topographical shape of an object. The device comprises an arrayed confocal imaging system having a confocal topographical mask provided for converting light produced by a light source into an array of small spots. The mask being mounted on a scanning member provided for moving the mask over successive positions over a predetermined distance. The device further comprises a confocal objective provided for mapping at successive object-position-in-focus the array of small spots output at said successive positions. The confocal objective may be mounted at a fixed position within said device.
Type:
Grant
Filed:
May 15, 2003
Date of Patent:
November 4, 2008
Assignee:
ICOS Vision Systems N.V.
Inventors:
John Zabolitzky, Carl Smets, Ludo Verluyten, August Smeyers
Abstract: A system for providing mobile interactive satellite services includes a satellite operable to communicate with mobile units, a terrestrial base transceiver station operable to communicate with mobile units, and a ground station in communication with the satellite and the terrestrial base transceiver station to provide mobile interactive satellite services. The mobile interactive satellite services include a multicast component and an interactive component such that the ground station provides both the multicast component and the interactive component using the satellite, with the terrestrial base transceiver station used to provide an ancillary terrestrial component. A device for communicating with a mobile interactive satellite service system includes an antenna, a transceiver coupled to the antenna and operable to communicate with a mobile interactive satellite service system, a user input device, an output device, a processor unit, and a network interface.
Type:
Application
Filed:
April 30, 2007
Publication date:
October 30, 2008
Applicant:
ICO Satellite Services G.P.
Inventors:
David Robert Zufall, Gerard Daniel Mulford, Stefan Bernard Raab, Mariam Aghdasi Sorond, Marcus John Le Maitre
Abstract: The invention relates to a gripper for handling frames (2) that are covered with a film (3) that is intended for the transport of wafers (6). The gripper comprises at least two flat fingers (10) that carry flattened finger tips (8). This construction allows to insert the gripper between two frames (2) that are mounted in a cassette (9) without complication. The fingers (10) support in subsections both the frame (2) and the film (3). The film is attached to the frame due to the suction effect exerted by vacuum openings (5) configured on the frame, thereby fixating the film on the gripper.
Type:
Grant
Filed:
December 4, 2003
Date of Patent:
October 14, 2008
Assignee:
ICOS Vision Systems N.V.
Inventors:
Detlef Gerhard, Johannes Lechner, Martin Renner
Abstract: The present invention relates in part to compounds of formulas (I) and (III): and pharmaceutically-acceptable salts and prodrugs thereof. These compounds can be useful for treating diseases such as inflammatory and immune diseases. The present invention also relates to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a subject.
Type:
Application
Filed:
April 28, 2005
Publication date:
September 25, 2008
Applicants:
ICOS Corporation, Biogen Idec MA Inc.
Inventors:
Kevin Guckian, Daniel Scott, Irina Jacobson, C.Gregory Sowell
Abstract: An illumination unit comprising a high-power light source (1), a first optical element (12) for focusing the light emitted from the high-power light source (1), a photometric head (8) for illuminating an object (3) in a predefinable manner, an optical waveguide (2) for transmitting the emitted and focused light to the photometric head (8), a displacement unit (6) for varying the axial distance between the high-power light source (1) with the first optical element (12) and the inlet of the optical waveguide, wherein the cross-sectional surface of the focal point is at least twice as large as the cross-sectional surface of the optical waveguide (2) on the light inlet side, and the intensity of the light coupled into the optical waveguide (2) can be varied by axial displacement of the high-power light source (1).
Abstract: A method and an apparatus for measuring respective positions of a set of N contact elements of an electronic component. A first and a second light path are created by a first and a second light beam which have different viewing angles. Both the first and the second light path can selectively be opened and both end into the image plane of a single camera. The positions being determined by using the first and second image produced by the first and second light beam respectively.
Type:
Grant
Filed:
January 2, 2002
Date of Patent:
September 9, 2008
Assignee:
Icos Vision Systems NV
Inventors:
Carl Smets, Karel Van Gils, John Zabolitsky, Jurgen Everaerts
Abstract: Substituted urea compounds useful in the treatment of diseases and C1-3alkyleneOR3 conditions related to DNA damage or lesions in DNA replication are disclosed formula (I), wherein X1 is null, —O—, —S—, —CH2—, or —N(R1)—; X2 is —O—,. -£>.-, or —N(R1)—, -..
Abstract: The orientation of the surface of an object to be examined is changed by adjusting the distance thereof to an optical measuring system in a plane-parallel manner in relation to a focusing plane of the optical measuring system, enabling high speeds of examination to be obtained during examination of the extended surfaces of the object. A distance-measurement system which is mounted in an auxiliary manner with regard to the measuring head enables fluctuations in the topography inside the surface of the object to be compensated in such a way that a currently received point or area can be optically sharpened.
Abstract: Compounds of formula (I) in which R1=C1-6 alkyl, optionally halosubstituted; R2=H, C1-4 alkyl, optionally halosubstituted or replaced by halogen; R3=C2-4 alkyl, optionally halosubstituted; R4=SO2NR5R&, CO2R7 or halogen, C2-4 alkenyl; optionally substituted with NR5R6, SONR5R6, CONR5R6, CO2R7 or halogen, C2-4 alkanoyl, optionally substituted with NR5R6, SONR5R6, CONR5R6, CO2R7 or halogen; R5 and R6=independently H or C1-4 alkyl, or, together with the N atom to which they are attached, a pyrrolidino, piperidino, morpholino, 4-(NR8)-1-piperazinyl or 1-imidazolyl ring optionally substituted with one or two C1-4 alkyl groups; R7=H, C1-4 alkyl, optionally fluorosubstituted, and R8=H,C1-3 alkyl or hydroxyalkyl with 1-4 C atoms, or the pharmaceutically acceptable salts thereof are useful for the chemotherapeutic treatment of neuropathies.
Abstract: A method and apparatus for wavefront analysis including obtaining a plurality of differently phase changed transformed wavefronts corresponding to a wavefront being analyzed which has an amplitude and a phase, obtaining a plurality of intensity maps of the plurality of phase changed transformed wavefronts and employing the plurality of intensity maps to obtain an output indicating the amplitude and phase of the wavefront being analyzed.
Abstract: The present invention is directed to combination therapies and drug delivery devices comprising antisense oligonucleotides directed to a raf gene. In certain embodiments, the combination therapies and drug delivery devices of the present invention are used to treat cancers and ocular diseases.
Abstract: A method of synthesizing a chiral compound having a quaternary carbon atom bearing diastereotopic groups from (a) a nitroolefin and (b) an ?-substituted ?-dicarbonyl or an equivalent compound having an acidic C—H moiety compound is disclosed. A subsequent intramolecular reaction between one of the substituents comprising the stereogenic carbon atom and one of the diastereotopic groups comprising the quaternary carbon atom creates a new compound having two contiguous stereogenic centers, one of which is quaternary, with control over the relative stereochemistry.
Type:
Application
Filed:
April 19, 2004
Publication date:
November 29, 2007
Applicant:
ICOS CORPORATION
Inventors:
Lisa Schultze, John Demattei, Brad Barnett, Anthony Piscopio, Paul Nichols
Abstract: The present invention relates in part to compounds of formulas I and III: and pharmaceutically-acceptable salts and prodrugs thereof. These compounds can be useful for treating diseases such as inflammatory and immune diseases. The present invention also relates to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a subject.
Type:
Application
Filed:
April 28, 2005
Publication date:
November 8, 2007
Applicants:
ICOS Corporation, Biogen Idec MA Inc.
Inventors:
Donovan Chin, Thomas Durand-Reville, Francine Farouz, Kerry Fowler, Kevin Guckian, Irina Jaconbson, Ramesh Kasar, Russell Petter, Daniel Scott, C. Gregory Sowell, Eugene Thorsett, Edward Yin-Shiang Lin
Abstract: A mobile station (4) in a satellite mobile telephone system predicts when it will move into another cell on the basis of one set of broadcast information thereby reducing the overall processing burden. The mobile station (4) can predict with a useful degree of certainty which broadcast control channel (BCCH) frequencies it should listen on when it wakes up on the basis of a stored map of the relative positions of cells. The broadcast information includes information about the current cell's (40) shape (V1, V2, V3, V4, V5, V6) and translational (T) and rotational (R) motion.
Abstract: The present invention relates to improved methods for inhibiting aberrant cell proliferation involving the scheduling of administration of Chk1 activators (e.g., chemotherapeutic agents) and Chk1 inhibitors. At least one Chk1 activator is administered at a dose and for a time sufficient to induce substantial synchronization of cell cycle arrest in proliferating cells. Upon achieving substantial phase synchronization, at least one Chk1 inhibitor is administered to abrogate the cell cycle arrest and induce therapeutic cell death. The invention is useful with any Chk1 activator and any Chk1 inhibitor, and finds application in treating or preventing cancerous and non-cancerous aberrant cell proliferation.